Aerie and Santen have entered an agreement for Rhopressa and Rocklatan in Europe, China, India, Commonwealth of Independent State countries, parts of Latin America and Oceanic countries, according to a company press release.
“We are delighted to announce this development and commercialization agreement with Santen, a leading global ophthalmology company, which will extend the benefits of our unique products to patients with glaucoma or ocular hypertension in Europe and several other global regions,” Benjamin F. McGraw II, PharmD, interim executive chairperson of the board of